Effect of Intensive Periodontal Therapy on Vascular Function
Effects of Non-Surgical Periodontal Therapy on Endothelial Function A Randomized Controlled Clinical Trial
1 other identifier
interventional
120
1 country
2
Brief Summary
The hypothesis of the existence of a causal association between the systemic infectious/inflammatory burden represented by periodontitis and endothelial function assessed by flow mediated dilatation of the brachial artery (FMD) is the subject of the proposed investigation. The objective of this randomized controlled clinical trial is to evaluate the effects of periodontal therapy on endothelial function assessed by Flow mediated dilatation (FMD). The rationale for this project is twofold:
- Establish the extent of acute systemic inflammation and endothelial dysfunction associated with the delivery of subgingival instrumentation for the treatment of chronic periodontitis
- Establish whether or not improved control of chronic periodontal infections results in improved endothelial function and thus the existence of a causal association between periodontitis and endothelial dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Sep 2003
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
May 16, 2006
CompletedFirst Posted
Study publicly available on registry
May 18, 2006
CompletedMay 18, 2006
March 1, 2005
May 16, 2006
May 16, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Flow mediated dilatation of the brachial artery
Secondary Outcomes (1)
Serum inflammatory and endothelial function markers
Interventions
Eligibility Criteria
You may qualify if:
- Between the ages of 35 and 60 and in good general health.
- Ability and willingness to follow study procedures and instructions.
- Must have read, understood and signed the Informed Consent.
- Must have generalized, moderate to advanced chronic periodontitis.
- pockets with a PD of \> 5 must bleed on probing.
- Absence of other significant oral infections.
You may not qualify if:
- Pregnant or lactating females or females of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence).
- Patients chronically treated (i.e., two weeks or more) with any vasoactive medication (i.e., antihypertensive) or lipid lowering therapy.
- Patients who started taking nonsteroidal anti-inflammatory drugs within two months prior to the baseline visit.
- Diagnosis of uncontrolled metabolic diseases including diabetes, kidney, liver, or cardiovascular diseases.
- Use of systemic antibiotics in the preceding 3 month.
- Patients taking steroid medications except for acute topical treatment.
- Patients with active infectious diseases such as hepatitis, HIV, or TB.
- Patients who require antibiotic pre-medication for the performance of periodontal examination or treatment.
- Patients who received a course of periodontal treatment within the last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eastman Dental Insitute and Hospitallead
- University College London Hospitalscollaborator
- British Heart Foundationcollaborator
- The European Research Group on Periodontology (ERGOPerio)collaborator
- Johnson & Johnsoncollaborator
- CORDA, The Heart Charitycollaborator
- European Social Fundcollaborator
- Italian Society of Periodontologycollaborator
Study Sites (2)
UCL Eastman Dental Institute and Hospital
London, WC1X 8LD, United Kingdom
UCL Vascular Biology Laboratory - Great Ormond Street Hospital
London, United Kingdom
Related Publications (7)
D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J. 2006 May;151(5):977-84. doi: 10.1016/j.ahj.2005.06.018.
PMID: 16644317BACKGROUNDD'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005 Mar;84(3):269-73. doi: 10.1177/154405910508400312.
PMID: 15723869BACKGROUNDD'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004 Feb;83(2):156-60. doi: 10.1177/154405910408300214.
PMID: 14742655BACKGROUNDD'Aiuto F, Tonetti MS. Contribution of periodontal therapy on individual cardiovascular risk assessment. Arch Intern Med. 2005 Sep 12;165(16):1920-1. doi: 10.1001/archinte.165.16.1920. No abstract available.
PMID: 16157839BACKGROUNDD'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine. 2004 Oct 7;28(1):29-34. doi: 10.1016/j.cyto.2004.06.005.
PMID: 15341923BACKGROUNDD'Aiuto F, Parkar M, Tonetti MS. Periodontal therapy: a novel acute inflammatory model. Inflamm Res. 2005 Oct;54(10):412-4. doi: 10.1007/s00011-005-1375-4.
PMID: 16283108BACKGROUNDD'Aiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS. Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol. 2004 May;31(5):402-11. doi: 10.1111/j.1600-051X.2004.00580.x.
PMID: 15086624BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maurizio Tonetti, DMD PhD
University College London Hospitals and University of Connecticut Health Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 16, 2006
First Posted
May 18, 2006
Study Start
September 1, 2003
Study Completion
March 1, 2005
Last Updated
May 18, 2006
Record last verified: 2005-03